SBC Medical Group Holdings Incorporated

SBCNASDAQIndustrials● Active

$3.00

$-0.01(-0.33%)

Market Cap$308540850

P/E Ratio—

52W High$5.75

52W Low$2.78

Avg Volume113K

Open$3.00

Beta0.59

Free Cash Flow Financials Revenue

SBC Medical Group Holdings Incorporated (SBC) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

SBC · free cash flow · updated Jun 8, 2026

Core FCF metrics

SBC · FCF · TTM · margin & CAGR

Free cash flow was $36.6M for FY2025 (fiscal year ending 2025-12-31), up 112.8% year-over-year The FCF margin was 21.1%.

FY2025 Free Cash Flow$36.6M▲ +112.8% YoY

Trailing 12M (TTM)$44.1Mtrailing 4 quarters sum

FCF Margin21.1%$36.6M ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

SBC · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest$38.9M(2M)$36.6M▲ +112.8%21.1%

FY2024$20.6M(3M)$17.2M▼ 56.4%8.4%

FY2023$50.6M(11M)$39.4M▲ +257.8%20.4%

FY2022−$47,369(25M)−$25.0M—-14.3%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

SBC · P/FCF · FCF yield · FCF per share

SBC Medical Group Holdings Incorporated (SBC) trades at a FCF yield of 14.28% and a price-to-free-cash-flow ratio of 7.0x. FCF per share stands at $0.43, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)

14.28%

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

$0.43

TTM FCF ÷ Shares Outstanding

Price / FCF

x7.0

Share Price ÷ FCF per Share

EV / FCF (TTM)

x3.7

Enterprise Value basis

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31

Cash flow statement summary

SBC · cash flow statement · operating / investing / financing

For FY2025, SBC Medical Group Holdings Incorporated generated $38.9M in operating cash flow and spent 2M in capital expenditures, yielding $36.6M in free cash flow.

Operating Activities

+$38.9M

Cash from core business operations

2025-12-31

Investing Activities

−$21.0M

CapEx, acquisitions & investments

2025-12-31

Financing Activities

+$24.0M

Buybacks, dividends & debt

2025-12-31

FCF FormulaOperating CF ($38.9M) − |CapEx| (2M) = FCF ($36.6M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Industrials)

SBC vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

SBC Medical Group Holdings IncorporatedYOU

SBC

$36.6M+112.8%21.1%

Space Exploration Technologies Corp.

SPCX

−$13.95B-159.0%-74.7%

Loss

Industrials · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

SBC Medical Group Holdings Incorporated (SBC) reported free cash flow of $36.6M for FY2025 (fiscal year ending 2025-12-31), up 112.8% year-over-year. The FCF margin was 21.1%.

Based on available data, SBC Medical Group Holdings Incorporated has maintained positive free cash flow for at least 3 fiscal year(s). FCF peaked at $39.4M in FY2023.

SBC Medical Group Holdings Incorporated's FCF yield is 14.28% and price-to-FCF ratio is 7.0x for FY2025, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

SBC free cash flow · 8 questions

SBC Medical Group Holdings Incorporated free cash flow was $36.6M for FY2025, up 112.8% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $44.1M.

SBC free cash flowSBC FCFSBC FCF 2025SBC free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · SBC Medical Group Holdings Incorporated · SBC Medical Group Holdings Incorporated SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026